References in periodicals archive ?
However, to estimate the efficacy of 5 doses of diphtheria vaccine, we restricted the analysis to children 5-10 years of age because the fifth dose of the vaccine is given to children >4.
In March 2007, Akorn announced that it had entered into an exclusive distribution agreement with Massachusetts Biologic Laboratories for Tetanus Diphtheria vaccine.
Further, the current year period included introductory pricing levels for the multi-dose Tetanus Diphtheria vaccine, necessary to compete with distributors who are exhausting their on-hand inventories prior to product expiration.
The current annual market for Tetanus Diphtheria Vaccine is approximately $230 million.
This is based on the re-launch of IC-Green[TM], which requires us to successfully pass a pre-approval inspection at our Decatur manufacturing facility, the commercial launch of Tetanus Diphtheria Vaccine, and the launch of our Advanced Vision Research contract manufacturing agreement for TheraTears[R].
Clearly, our announcement to exclusively market and distribute tetanus diphtheria vaccine is vital to our short and long-term financial success.
Przybyl, Akorn's President and Chief Executive Officer stated, "We are excited to enter into this Exclusive Agreement with Massachusetts Biologic Laboratories, and look forward to introducing MBL's new single-dose, preservative-free Tetanus Diphtheria vaccine.
Aventis Pasteur became the primary national supplier of the tetanus and diphtheria vaccine last year when another manufacturer abruptly withdrew from the market.
Behringwerke's vaccine products have their roots in the pioneering work of its founder, Emil von Behring, who received the first Nobel Prize in medicine, in 1901, for his discovery of passive immunity, which led to the development and large-scale manufacture of diphtheria antisera and the diphtheria vaccine.
While there can be mild side effects from the diphtheria vaccines such as a fever or a sore arm, serious reactions are about one in a million.
Additionally, the Company announced the receipt of a contract award for the Centers for Disease Control and Prevention (CDC) for Tetanus Diphtheria Vaccines and renegotiated its Exclusive Distribution Agreement for Td Vaccines on favorable terms.
Akorn also announced the receipt of a contract award from the Centers for Disease Control and Prevention (CDC) for Tetanus Diphtheria Vaccines.

Full browser ?